Literature DB >> 22585287

Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individuals.

Beau K Nakamoto1, Neda Jahanshad, Aaron McMurtray, Kalpana J Kallianpur, Dominic C Chow, Victor G Valcour, Robert H Paul, Liron Marotz, Paul M Thompson, Cecilia M Shikuma.   

Abstract

HIV-associated neurocognitive disorder remains prevalent in HIV-infected individuals despite effective antiretroviral therapy. As these individuals age, comorbid cerebrovascular disease will likely impact cognitive function. Effective tools to study this impact are needed. This study used diffusion tensor imaging (DTI) to characterize brain microstructural changes in HIV-infected individuals with and without cerebrovascular risk factors. Diffusion-weighted MRIs were obtained in 22 HIV-infected subjects aged 50 years or older (mean age = 58 years, standard deviation = 6 years; 19 males, three females). Tensors were calculated to obtain fractional anisotropy (FA) and mean diffusivity (MD) maps. Statistical comparisons accounting for multiple comparisons were made between groups with and without cerebrovascular risk factors. Abnormal glucose metabolism (i.e., impaired fasting glucose, impaired glucose tolerance, or diabetes mellitus) was associated with significantly higher MD (false discovery rate (FDR) critical p value = 0.008) and lower FA (FDR critical p value = 0.002) in the caudate and lower FA in the hippocampus (FDR critical p value = 0.004). Pearson correlations were performed between DTI measures in the caudate and hippocampus and age- and education-adjusted composite scores of global cognitive function, memory, and psychomotor speed. There were no detectable correlations between the neuroimaging measures and measures of cognition. In summary, we demonstrate that brain microstructural abnormalities are associated with abnormal glucose metabolism in the caudate and hippocampus of HIV-infected individuals. Deep gray matter structures and the hippocampus may be vulnerable in subjects with comorbid abnormal glucose metabolism, but our results should be confirmed in further studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585287      PMCID: PMC3420956          DOI: 10.1007/s13365-012-0106-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  40 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Clinical contributors to cerebral white matter integrity in HIV-infected individuals.

Authors:  Assawin Gongvatana; Ronald A Cohen; Stephen Correia; Kathryn N Devlin; Jadrian Miles; Hakmook Kang; Hernando Ombao; Bradford Navia; David H Laidlaw; Karen T Tashima
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

Review 3.  Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review.

Authors:  Yaniv Assaf; Ofer Pasternak
Journal:  J Mol Neurosci       Date:  2008       Impact factor: 3.444

4.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

5.  Structural gray and white matter changes in patients with HIV.

Authors:  Michael Küper; K Rabe; S Esser; E R Gizewski; I W Husstedt; M Maschke; M Obermann
Journal:  J Neurol       Date:  2011-01-05       Impact factor: 4.849

6.  Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

Authors:  E J Wright; B Grund; K Robertson; B J Brew; M Roediger; M P Bain; F Drummond; M J Vjecha; J Hoy; C Miller; A C Penalva de Oliveira; W Pumpradit; J C Shlay; W El-Sadr; R W Price
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

7.  Subcortical brain atrophy persists even in HAART-regulated HIV disease.

Authors:  James T Becker; Joanne Sanders; Sarah K Madsen; Ann Ragin; Lawrence Kingsley; Victoria Maruca; Bruce Cohen; Karl Goodkin; Eileen Martin; Eric N Miller; Ned Sacktor; Jeffery R Alger; Peter B Barker; Priyanka Saharan; Owen T Carmichael; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2011-06       Impact factor: 3.978

Review 8.  Morphologic diagnosis of "vascular dementia" - a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2008-05-02       Impact factor: 3.181

9.  Frontostriatal fiber bundle compromise in HIV infection without dementia.

Authors:  Adolf Pfefferbaum; Margaret J Rosenbloom; Torsten Rohlfing; Carol A Kemper; Stanley Deresinski; Edith V Sullivan
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

10.  Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study.

Authors:  Todd T Brown; Xiaoqiang Xu; Majnu John; Jaya Singh; Lawrence A Kingsley; Frank J Palella; Mallory D Witt; Joseph B Margolick; Adrian S Dobs
Journal:  AIDS Res Ther       Date:  2009-05-13       Impact factor: 2.250

View more
  13 in total

Review 1.  Novel Neuroimaging Methods to Understand How HIV Affects the Brain.

Authors:  Paul M Thompson; Neda Jahanshad
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

2.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Authors:  Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

3.  Abnormal Cerebral Perfusion Profile in Older Adults with HIV-Associated Neurocognitive Disorder: Discriminative Power of Arterial Spin-Labeling.

Authors:  J Narvid; D McCoy; S M Dupont; A Callen; D Tosun; J Hellmuth; V Valcour
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-22       Impact factor: 3.825

Review 4.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford; Beau M Ances
Journal:  Lancet Infect Dis       Date:  2013-11       Impact factor: 25.071

Review 5.  HIV and aging: effects on the central nervous system.

Authors:  Silvia Cañizares; Mariana Cherner; Ronald J Ellis
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

6.  Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Authors:  David E Vance; Graham J McDougall; Natalie Wilson; Marcus Otavio Debiasi; Shameka L Cody
Journal:  Top Geriatr Rehabil       Date:  2014-01

Review 7.  The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research.

Authors:  David E Vance; Pariya L Fazeli; Joan E Dodson; Michelle Ackerman; Michele Talley; Susan J Appel
Journal:  J Neurosci Nurs       Date:  2014-10       Impact factor: 1.230

8.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

9.  Independent and Combined Effects of Chronic HIV-Infection and Tobacco Smoking on Brain Microstructure.

Authors:  Huajun Liang; Linda Chang; Rong Chen; Kenichi Oishi; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-17       Impact factor: 4.147

10.  Deep Learning and Multivariable Models Select EVAR Patients for Short-Stay Discharge.

Authors:  Devin S Zarkowsky; Besma Nejim; Itay Hubara; Caitlin W Hicks; Philip P Goodney; Mahmoud B Malas
Journal:  Vasc Endovascular Surg       Date:  2020-09-10       Impact factor: 1.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.